http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021185192-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d78704ae984a9ba6e58c3548e3ff0701
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
filingDate 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bfeb92083b71eb4b99a90ca06174ce6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_563c8580f74bac00310138497203e02e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f47e4ba706f97a7ff35dd3a2b7b54b0
publicationDate 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021185192-A
titleOfInvention Aryl Receptor Modulator and Its Preparation and Usage
abstract PROBLEM TO BE SOLVED: To provide an aryl receptor modulator and a method for producing and using the same. The present invention generally relates to compounds capable of binding and modulating the activity of aryl hydrocarbon receptors, methods of treating inflammatory conditions such as Crohn's disease using such compounds, and the like. The target is a pharmaceutical composition containing such a compound. Also provided are methods of increasing IL-22 levels of a subject and / or reducing IFN-γ levels of a subject. The inflammatory diseases or conditions treated by the compounds of the present invention include inflammatory bowel disease, cartilage inflammation, osteolysis, ulcerative colitis, psoriasis, arthritis, psoriasis arthritis, rheumatoid arthritis, juvenile arthritis, juvenile joints. A group consisting of rheumatism, autoimmune hepatitis, Crohn's disease, lupus erythematosus, multiple sclerosis, Alzheimer's disease, dermatitis, atopic dermatitis, psoriasis, type I diabetes, Reynaud's phenomenon, Graves' disease, and Azison's disease. Will be selected. [Selection diagram] None
priorityDate 2014-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008536876-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003040527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010521435-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466384464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421950793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413822154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467412124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428880083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421720654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2797079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466338845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466783259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118617126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118617127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466639095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428880077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468043580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467726172

Total number of triples: 82.